Biosim Revenue and Competitors
Employee Data
Biosim's People
| Name | Title | Email/Phone |
|---|
Biosim Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Biosim?
BiosimAI has joined forces with Deep Origin. The combined company is accelerating drug discovery by combining cutting-edge quantum chemistry, biophysics simulation, AI, and scientific computing. We aim to reduce small-molecule drug discovery from years to months. Our world-class team is led by our founders Michael Antonov and Garegin Papoian. To join our team, please see our job openings.
keywords:N/A
N/A
Total Funding
N/A
Number of Employees
N/A
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator